Tag Archives: Venue

Revisiting Foreign Infringing Activity

Patent.Law053CNET v. ETILIZE, 2007 U.S. Dist. LEXIS 87205 (N.D. Cal. 2007).

CNET sued Etilize for infringement of its patented method and system for creating an electronic website catalog.  

International Infringement: The accused infringer Etilize employs Pakistanis (in Pakistan) to manually comb the Internet and update its database of websites.

Method and System Claims: Because Etlilize performs some steps of the patented method outside of the US, it cannot be found to infringe the method claims under 35 U.S.C. 271(a).

On the other hand, CNET argued that the system claim would be infringed because the control and beneficial use of the system stems from the US. (NTP v. RIMM). On summary judgment, Judge Patel distinguished the RIMM decision and sided with the accused infringer. In particular, the court found that the claimed “system for creating” was not controlled or used by American end-users of the compiled data.

That a copy of the catalog is located on a server in the United States … does not change the fact that overall control of the data collection and catalog creation is exercised from Pakistan.

Import under 271(g): 35 U.S.C. 271(g) provides an additional avenue for capturing foreign infringement. That statute specifically charges importation of a product made by a patented process. Under Bayer v. Housey and NTP, this statute has been limited to physical products that have been manufactured.

Here, Judge Patel found that the electronic catalog (when stored on computer readable media) is a physical product and qualifies under 271(g).  In Microsoft v. AT&T, the Supreme Court followed the same analysis in holding that “a copy of Windows, not Windows in the abstract qualifies as a ‘component’ under 271(f).”

Patently-O Bits and Bytes No. 2

  • Patent Reform: A draft report on S.1145 is available here.  [via PatentDocs]. Although currently supported by more Democrats than Republicans, this is a bipartisan bill that could pass. A summary:
  • Change the system to a “first-inventor-to-file” system;
  • Reduce patent damage awards;
  • Enhance post-grant opposition proceedings;
  • Provide for publication of all applications;
  • Allow for better third-party submissions;
  • Limit patent infringement venues;
  • Allow the PTO to set its own fees;
  • Remove the residency restriction for judges on the United States Court of Appeals for the
    Federal Circuit;
  • Authorize USPTO to require pre-filing patent searches and explanations;
  • Re-vamp the doctrine of inequitable conduct;
  • Clarify the rules on unintentional delays in filing;
  • Limit patent infringement liability for electronic check processing;and
  • End USPTO “fee diversion”.
  • Patent Reform: Remember, the House has already passed the companion bill. Passage could allow President Bush to ride out of office as the innovation president.
  • Patent Baristas discusses PTO’s “Suspicious Behavior” in the Tafas case.
  • Patent Litigation Trends: Survey Results

    PatentLawPic124Fulbright & Jaworski recently released some results from its survey of 300 GC’s (and AGC’s) at large US & UK companies. Results:

    • Very large companies (>$1B) are much more likley to be hit with charges of patent infringement than are smaller companies (<$100m).  Unlike smaller companies, the very large companies also claim that the quantity of charges are on the rise. A small percentage (~3%) of companies with a revenue greater than $100m have defended against more than 50 claims in the past three years.
    • For most defendants, the major concern is not the potential for an injunction, but rather the cost of litigating.
    • The very large companies are also more likely to be on the plaintiff side asserting their own patents. The report claims a close correlation between company size and likelihood of enforcing its patent claims through litigation.

    The report is free after you provide your contact info: Link. I can also e-mail a copy to you.

     

    Tax Strategy Patents

    PatentLawPic116The Internal Revenue Service is “concerned” about tax strategy patents and has issued a notice of proposed rules to require a special disclosure if a taxpayer uses a patented tax planning method to achieve a tax benefit. 

    The specific rules would require a special disclosure reporting a patent license anytime a taxpayer pays a fee (including indirect consideration) to a patent holder for the legal right to use a tax planning method that the taxpayer “has reason to know” is subject to a patent.  A tax planning method is defined as “any plan, strategy, technique, or structure designed to affect Federal income, estate, gift, generation skipping transfer, employment, or excise taxes.” The rule would exclude patents covering tax preparation software or “other tools used to perform or model mathematical calculations or to provide mechanical assistance in the preparation of tax or information returns.”  Under the rules, both the licensee and licensor (patent owner) would be required to submit the disclosure reporting the license transaction.

    One hole in the rule would allow non-licensed intentional infringers to use the patented tax strategy without filing any particular documentation. 

    This disclosure is akin to the recent proposal by Lemley & Myhrvold to require publication of all patent licenses. However, the IRS rule is much easier to implement because of a pre-existing enforcement structure and the relatively small number of tax strategy patents. In the tax strategy business, the disclosure could dramatically change the current status of highly secret meetings and extensive diversion tactics.

    Notes & Documents:

    • Any comments on the rules must be received by December 26, 2007. Once effected, the new rules will apply retroactively to September 26, 2007. Comments may be submitted through the eRulemaking portal at www.regulations.gov with reference to IRS-REG-129916–07. The IRS point of contact is Richard Hurst: Richard.A.Hurst@irscounsel.treas.gov (202) 622–7180.
    • Federal Register Publication: http://patent.googlepages.com/TaxPatents.pdf.
    • Senator Obama has proposed an amendment to 35 USC 101 to eliminate tax shelter patents [Link].
    • More info from Paul Caron — the “TaxProf” [Link][Link].

    Some Tax Strategy Patents:

    • 6,567,790: Funding of a GRAT with nonqualified stock options.
    • 6,292,788: Tax-deferred real estate transaction.
    • 7,149,712: Purchase of an annuity contract to fund a charitable remainder trust.
    • 7,177,829: Tax Refund System (HRBlock Software).

    The Waning of the Eastern District of Texas (as a Patent Venue)

    Although still the most popular district court for new patent cases. The magnetism of the Eastern District of Texas may be beginning to wane. Two recent cases:

    • Weinstein v. UGS Corp: This is not a patent case — however it may be indicative of the court’s new favorite word: Transfer. Here, the court transferred a civil case back to Michigan were the best locus of facts and witnesses could be found.
    • TGIP v. AT: TGIP won a $156 million patent infringement verdict — the largest patent verdict ever in the Eastern District of Texas. After the verdict, the district court erased the award — awarding judgment as a matter of law for AT&T. Apparently, the jury decision did could not properly account for technical details regarding the call authorization code timing.

    Michael Smith calculates the 2007 patentee win rates at 28% (2 of 7). If Patent Reform 2007 becomes law, new filings will likely dry up quickly (becaues the venue will be improper for most cases).

    Some evidence to the contrary —over 15% of new patent lawsuits filed between August 1, 2007 and November 1, 2007 were filed in the Eastern District of Texas (Westlaw Docket Reports). 

    Documents:

     

     

    CAFC Continues to Support Strong State Immunity from Patent Infringement

    BPMC v. California Department of Health (Fed. Cir. 2007).

    There is a reason why states generally support strong patent rights: States are increasingly major patent holders – based on inventions developed through federal grants. At the same time, states are generally immune from being sued for infringement. In this case, the CAFC allows the State of California to assert immunity based essentially on a case-numbering technicality.

    The facts are simple: Kaiser filed a declaratory judgment action against the patent holder BPMC back in 1997. The California DOH intervened in that case — an action generally considered a waiver of immunity. That case was dismissed for improper venue. In 2006, BPMC filed an identical (mirror image) infringement action against the DOH asserting the identical patent and issues and in the same venue as the 1997 action. The issue here is whether the waiver in the original case of California’s 11th Amendment immunity applies also to the new case. 

    Here, the CAFC narrowly construed the state’s waiver of immunity to be strictly limited to the same action. The court noted precedent that the waiver would apply if BPMC had been able to file its case as a revival of the original action an “numbered as that cause of action.”

    The appellate panel also rejected BPMC’s argument that the DOH should be judicially estopped from changing its position in this litigation. According to the court, the about-face was excusable because of an intervening change in the law of immunity. (Florida Prepaid). 

    Expect that this case will receive a petition for certiorari.

    Notes:

    Personal Jurisdiction: Patent Plaintiff must Link Accused Product with Accused Defendant

    F&G Research v. Paten Wireless (Fed. Cir. 2007)(Nonprecedential)

    Part of the Congressional patent reform package focuses on venue reform. Defendants are tired of being sued in the Eastern District of Texas.

    In this case, F&G sued Paten in the Southern District of Florida — alleging that Paten’s infringing computer mouse components were being distributed in the state.

    On appeal, the CAFC affirmed the lower court’s dismissal of the case — finding that F&G failed to show that Florida courts have personal jurisdiction over the defendant. The Florida long-arm statute allows for specific jurisdiction over parties who commit tortious acts within Florida. The plaintiff has the burden of providing evidence of those acts.

    Here, F&G showed that Paten sold components to several companies doing business in Florida (e.g., Logitech, Belkin, and Creative Technology) and also showed that accused products were being sold in Florida. However, the plaintiff did not provide evidence that the accused products sold in Florida were Paten’s products. Thus, no personal jurisdiction.

    New Evidence on Appeal: At the appeal stage, F&G presented some evidence that Paten’s products were being sold in Florida. However, the CAFC refused to hear that new evidence. Although personal jurisdiction may be raised sua sponte by the appellate court, the court will not conduct de novo fact finding regarding jurisdiction.

    What now?: Although now armed with more evidence of personal jurisdiction, F&G would likely be blocked from filing in Florida because the issue has already been decided between the parties. There are, of course, several hundred other venues available within the US.

    Continued Patent Trouble for Vonage

    Verizon v. Vonage (Fed. Cir. 2007)

    Judge Dyk wrote the majority opinion. Each of the five substantive sections of the opinion garnered two votes. Chief Judge Michel joined Parts I and V while Judge Gajarsa joined Parts II-IV. Both Judges Michel and Gajarsa filed additional dissenting opinions.

    Earlier in 2007, Vonage was found to infringe three of Verizon’s IP Telephony patents. The verdict awarded $58M in damages along with an ongoing 5.5% royalty rate and an injunction against further infringement.

    On appeal, the CAFC affirmed that two of the patents were valid and infringed and that an injunction had been properly granted. As to the third patent (the ‘880 patent), the CAFC vacated and remanded after finding claim construction errors, potential errors in application of the obviousness doctrine under KSR, and errors in determining injunctive relief under eBay. The damage award was also vacated because the jury verdict did not apportion damages according to the various patents.

    Thus, Vonage still infringes, but perhaps not as severely. It is unclear at this point whether avoiding infringement of one patent helps Vonage in any substantive way…

    Chief Judge Michel would have affirmed across the board. And, interestingly, he would not have disturbed the $58M damage award even though one of the three patents was not infringed.

    “When, as here, the evidence shows that each of the accused products infringes all of the patents-in-suit, and the infringer fails to make any showing on appeal that the damages award would not be supported by only those patents for which we affirm liability, we must affirm the damages despite our reversal of part of the infringer’s liability.”

    Judge Gajarsa found claim construction errors in one other Verizon patent, but could not convince a colleague.

    ============

    Sprint v. Vonage (E.D.Kan. 2007) On September 25, a Kansas City jury found that Vonage also infringes a patent held by Sprint Nextel — tacking on another 5% in royalty revenue. [LINK].

    Notes:

    Patent Reform 2007: House of Representatives Passes H.1908

    Legislative patent reform still has a long road to travel before reaching its conclusion. However, the passage of H.1908 by the House of Representatives represents a major leap forward along the path. The following are some highlights of the statute as passed. [H.1908.As.Passed].

    First to file system: Obviousness and novelty would now be considered as of the “effective filing date.”  Novelty grace period would be eliminated except for the inventor’s own disclosures. Although unclear, the grace period appears to be completely eliminated for obviousness analysis. Interferences are gone.

    Damages: Reasonable royalty calculations (the most common damage awards) would all require courts to conduct a thorough analysis to ensure that damages are equal to the “economic value [of the invention] properly attributable to the patent’s specific contribution over the prior art.” The entire value of a product or process can only be the basis for royalty calculations if the innovation is the “predominant basis” for market demand of the product. (a showing that may be impossible in most cases). Overall this would reduce damage awards.

    Search Reports: PTO would be granted discretion in ordering search reports for all applications except those by a new group called ‘micro-entities.’

    Treble Damages: The statute explicitly calls-out ‘willfulness’ as the sole reason for enhanced damages then severely limits the facts where willfulness can be found. Overall this reduces the likelihood of awarding treble damages.

    Post-Grant Review: In addition to reexamination, a post-grant review proceeding would be available if filed within 12–months of issuance or with the patentee’s permission.

    Open Examination: Anyone may submit prior art for any patent or pending application along with an explanation of why the art is important.

    Tax Methods: A patent would not be available for a newly invented tax planning method. Tax planning methods do “not include the use of tax preparation software or other tools used solely to perform or model mathematical calculations or prepare tax or information returns.”

    Venue and Jurisdiction: Strong limitations on venue would likely eliminate E.D.Texas as a potential choice.

    Interlocutory Appeal: A district court would be given discretion to certify interlocutory appeals of claim construction decisions.

    Inequitable Conduct: Inequitable conduct must be pled with specificity following FRCP Rule 9b. Inequitable conduct rules would be made explicit in the statute. Overall, this weakens the defense of inequitable conduct.

    PTO Regulatory Power: The statute would give the PTO power to make the continuation rule changes that it has already implemented.

    Patent Trial and Appeal Board: Following John Duffy’s Suggestion, the statute would have the board appointed by the Secretary of Commerce rather than the PTO Director.

    Study of Patent Damages: The PTO will study how damage awards have changed based on the changes in the law.

    Upcoming Events

    When choosing a meeting or workshop to attend, I often prefer the smaller venues where you can really ask questions and easily meet your fellow attendees. Here are two that I have attended as a speaker and would recommend:

    I will be speaking at the Ocean Tomo Fall 2007 Live Auction in Chicago on October 24th & 25th. My topic: The Three Branches of Patent Reform. Look me up if you are around.

    Other events:

    DC is Improper Venue for Appeal of PTO Petition by Foreign Patentee

    PatentLawPic011Michilin Prosperity v. Dudas (D.D.C 2007)

    Michilin’s patented shredder is designed for handling both paper and CDs. Michilin’s claim 1 requires a “paper touch switch” and a “disc touch switch.” Claim 4, which depends upon claim 1, indicates a “single touch switch.”  Seeing a technical error, Michilin filed for a certificate of correction to transform claim 4 into an independent claim.  The PTO denied that request — indicating that a reissue may be the proper recourse. Michilin, a Taiwanese company, appealed the PTO’s denial to district court in the District of Columbia.

    On appeal, the PTO quickly requested dismissal based on venue — arguing that the case must be brought in Virginia.

    Venue Statutes:

    • 28 U.S.C. § 1391(e): Actions against a US Gov’t officer acting in his official capacity must be filed in a jurisdiction where (1) the defendant resides; (2) a substantial part of the claim arises; (3) the property is located; or (4) where the plaintiff resides if no real property is at issue.
    • 35 U.S.C. § 1(b): The residence of an official defendant is the “official residence” of the officer or agency.

    The PTO’s Virginia headquarters is both Mr. Dudas’s official residence and the site of the denial of Michilin’s request. That, according to the court makes Virginia the only proper venue for an appeal of this case. Case transferred to E.D.Va.

    Two failed arguments:

    1. Dudas is also an officer in the Department of Commerce, which is located in DC. This fails because Dudas is being sued in his capacity as Director of the USPTO.
    2. The patent is “located” in DC because Michilin had filed parallel patent infringement litigation in DC. This argument may have some weight, but failed here because that case had already been dismissed.

    Cite: Michilin Prosperity Co. v. Dudas, 2007 U.S. Dist. LEXIS 55216 (D.D.C. July 31, 2007).

    Broadened Continuation Receives Broad Construction; Enablement Questioned

    Saunders Group v. Comfortrac (Fed. Cir. 2007).

    Typical use of continuation practice: (1) Patentee files application claiming feature B1 (as the only described embodiment of generic class B). (2) Competitor releases product that would be infringing except for its feature B2. (3) Patentee files continuation that replaces B1 with the generic element B. (4) patent issues. What happens in upcoming litigation?

    This scenario, which is exemplified in Saunders Group, raises at least three particular litigation issues listed in order applicability: (1) whether the broad scope of element B has been properly enabled; (2) whether the specific element B1 is an essential element of the invention whose removal would be a violation of the written description requirement discussed in Gentry Gallery; and (3) whether the broad term B should be construed in a limited fashion to avoid problems 1 and 2 (applying the maxim that claims should be construed to preserve validity).

    We know from Saunders Group, of course, that it is impermissible to import limitations into a claim even when hoping to preserve validity of the claim.  Especially where here, there was no question that “the applicant expressly and unambiguously state[ed] his intention to claim broadly.”

    Here, the lower court had issued a summary judgment of non-infringement based on its narrow claim construction (construing B as B1). The CAFC reversed that holding, but suggested that invalidity under enablement is the correct avenue to pursue on remand:

    [W]e hold only that the court’s validity analysis cannot be used as basis for adopting a narrow construction of the claims. Instead, any validity issues that the defendants have preserved and wish to press can be addressed on remand, as was done in the Liebel-Flarsheim case. See Liebel-Flarsheim Co. v. Medrad, Inc., 481 F.3d 1371 (Fed. Cir. 2007) (holding invalid claims that had been given a broad construction at the patentee’s behest in an earlier appeal).

    Notes:

    • This type of case may soon be history if new continuation rules are truly effected.

    Stay Pending Appeal: Denied for Qualcomm at ITC

    USITCUS (Broadcom) v. Qualcomm (ITC 2007).

    The International Trade Commission (ITC) is an increasingly popular venue for patent infringement issues. The ITC’s only power is to enjoin imports (no money damages), but in competitor suits that is the optimal result.

    As part of a large ongoing patent battle, Broadcom filed a Section 337 action against Qualcomm — asserting that Qualcomm’s mobile-phone chip imports infringed Broadcom’s patent nos. 6,374,311, 6,714,983, and others. An administrative law judge (ALJ) sided with the patentee Broadcom, and the Commission affirmed (but limited the scope of injunction).

    Qualcomm and its supporters requested that the ITC stay relief pending appeal to the CAFC. 

    ITC Stays: Section 705 of the Administrative Procedure Act (APA) provides the ITC with authority for granting a stay. Generally, the ITC determines stays based on the same four factors used to determine whether to grant a preliminary injunction. (It is also approximately the same test used by the CAFC and discussed in Standard Havens).

    In order to obtain a stay pending appeal, the moving party must prove:

    • (1) a likelihood of success on the merits of the appeal (or an “admittedly difficult legal question”);
    • (2) irreparable harm absent a stay;
    • (3) that issuance of a stay would not substantially harm other parties; and
    • (4) that the public interest favors a stay.

    Here, the ITC determined (without reasoning) that Qualcomm had failed to satisfy the four-prong test.

    The CAFC is expected to make an independent determination regarding the stay within the next week.

    Notes:

  • Two of the six commissioners would have granted a stay.
  • A Dangerous Prosecution Trap

    ForkBy Paul F. Morgan

    I recently retired from a position in which I was also providing legal advice to patent application prosecution attorneys and others.  I had noted the following relatively frequent source of legal confusion in current law for some patent examiners, with the result that some patent prosecutors were being dangerously misled by incomplete examiner rejections. Hence, this warning note.   

    A prior U.S. PTO published patent application can qualify as prior art under multiple portions of 35 U.S.C. §102 – resulting in varying effective dates, and requiring different attorney or agent responses. Often, the multiple effective dates are not reflected in examiner rejections.  However, getting a patent application allowed incorrectly can be fatal to the patent’s validity or even lead to inequitable conduct accusations.  Legal misunderstandings of the patent examiner during ex parte prosecution do not create a valid legal excuse for prosecuting attorney legal errors.

    A published US patent application has a §102(e) prior art date as of that application’s filing date, and also a §102(a) or §102(b) prior art date as of its publication date. The office action rejection should discuss both dates if the publication date was prior to the rejected application.  But, even if the examiner’s rejection was legally incomplete, the applicant’s attorney must still overcome both, correctly.

    If the published application was commonly owned at the time of its invention, a §102(e)/103 rejection can be overcome by asserting common ownership under §103(c).    The protections of §103(c) do not apply to 102(a) or 102(b) prior publications.  Rather, that section only applies to 102(e),(f) and/or (g)!  Furthermore, §103(c) only applies to obviousness issues, not anticipation. Nor does §103(c) eliminate what should have been an alternative rejection for double patenting.  

    Obviously, a §102(b)/103 reference from an application publication date more than a year before the subject application date cannot be eliminated, only argued over.   While a §102(a)/103 rejection might be overcome by presenting evidence of an earlier invention date, that avenue is considerably more difficult and dangerous.  In particular, patents obtained via 37 CFR 1.131 declarations of alleged prior invention have a poor litigation record. Where appropriate, 102(a) prior art may be overcome by perfecting a valid priority claim to an earlier application. 

    One final related danger that arises from the fact that most U.S. applications are now  published within 18 months of their first filing date.  Even self-publications qualify as 102(b) prior art.  That means that patent applications on improvement inventions from the same client, especially with different or partially different inventors, need to be filed ASAP to avoid prior-filed basic applications from becoming prior art under §102(a) or (b) against the improvement applications [which cannot be avoided by §103(c).]

    The above, of course, is oversimplified, and other commentators may wish to “chip-in.” with practical advice.

    Notes:

    • Paul Morgan recently retired, as the Assistant General Patent Counsel
      for a major U.S. Corporation, after 44 total years of patent practice.

    Patent Reform Act of 2007: Preliminary Notes and Comment Part I

    This post provides some initial notes from my first read-through of the proposed legislation. More information regarding the proposal is available at an earlier post here.

    1. Top Secret Development: The proposed legislation was developed in-secret by a closed-group representing industry organizations.  As it turns out, however, the major big-industry players are not all on-board and neither are groups of would-be patent plaintiffs. The end-result is a bill that is heavily tilted toward providing additional avenues for challenging patent validity and for reducing the power of all patents.  In that sense, the Bill is a gift to potential defendants. In the end, the legislation is so one-sided that it is quite unlikely to move forward without a complete overhaul.
    2. No Grace Period?: The proposed first-to-file has been contentious for many years.  Proponents of the change talk about how Interference proceedings are an awful process and first-to-file avoids that problem. A first-to-file system automatically awards the patent to the first applicant who submits the patent application.  The proposed legislation, of course, does far more than ease resolution of interference disputes.  The proposal shifts all focus from an invention date to the “effective filing date” and in-the-process eliminates the US one-year grace period.  Notably, the grace period would still be intact for the inventor’s own disclosure. 
    3. Joint Research avoids Anticipation: The grace period is also still intact for disclosures made by the patent assignee — a provision clearly favoring companies with larger research-arms.  In addition, there is still a one-year filing grace-period for disclosures made by parties to a properly-written joint research agreement. 
    4. Public Use and On Sale Activity outside of the US would now be considered prior art.  This is probably justified by recently expanded extraterritorial effect of patent enforcement.
    5. Damages a new floor: The new damages proposal is very specific and sets a new (lower) floor for damages. Under the proposal, courts must conduct a reasonable royalty analysis focused at the “patent’s specific contribution over the prior art.”  The statutory language surrounding this analysis appears to be complex enough to occupy dozens of CAFC opinions explaining the proper methods of determining the economic value of the difference between the invention and the prior art.  Reasonable royalty does, however, remain only a floor — although according to the statute, it must now be calculated (even if going after lost-profits). (Jury Trial Issues?)
    6. Clear Path to Avoid Willfulness: Adios Treble Damages.  The patent community spends a considerable amount of time discussing willful infringement and the associated enhanced damages. The current patent statute, however, does not mention willful infringement allowing for additional theories for enhancing damages.  The amendment would limit treble damages only to cases where willfulness is found based on clear and convincing evidence of either (1) notice of how particular acts infringed particular claims or (2) intentional copying with knowledge of the patent or (3) continuing to sell the infringing product after being adjudge an infringer.  “Good faith” by the infringer avoids willfulness. Although the ‘rules’ regarding increased damages have been becoming ever more stratified, this statute removes the vast majority of the current leeway given to courts and juries.
    7. Bifurcation of Trials: Many defendants believe that juries are biased simply by hearing that they are accused of willful infringement. The reforms would bar a patentee from even alleging willfulness until after the patent has been found valid and infringed.
    8. Inter Partes Reexamination: Many patent litigators have warned clients against filing inter partes reexamination requests because of the litigation estoppel created by by 35 USC 315(c). That provision estopps later validity challenges on grounds that a third party “raised or could have raised” during the reexamination.  The Patent Reform Act would limit the estoppel to only issues actually raised — striking the “could have raised” language.

    Patent Reform Act of 2007

    On April 18, 2007, bipartisan legislators in both the Senate and House of Representatives introduced sweeping patent reform measures in legislation termed the Patent Reform Act of 2007. The reform measures include the following provisions: 

    • First-to-file rights and elimination of interference proceedings;
    • Reform to make it easier to file a patent application without the inventor’s cooperation;
    • Limitation of damages to only the economic value of the improvement as compared to the prior-art;
    • Specific limitations on when damages may be trebled for willfulness;
    • Post-grant opposition proceedings and a reduction in the litigation estoppel effect of reexaminations;
    • Limitations on patent venue;
    • Authority to the PTO director to create further regulations.

    Although couched in terms of the importance of patents and patent quality. The thrust of many of the measures are clearly directed at “limiting litigation abuses.”  The two versions (Senate and House) are appear virtually identical in substance.

    Analysis:

    • Inter Partes Reexamination: Many patent litigators have warned clients against filing inter partes reexamination requests because of the litigation estoppel created by by 35 USC 315(c). That provision estopps later validity challenges on grounds that a third party “raised or could have raised” during the reexamination.  The Patent Reform Act would limit the estoppel to only issues actually raised — striking the “could have raised” language.

    Legislative Documents:

    Congressional Players:

    • The Senate version was introduced by Senators Leahy, Hatch, Schumar, and Cornyn
    • The House version was introduced by Representatives Berman, Smith, Conyers, Coble, Boucher, Godlatte, Zoe Lofgren, Issa, Schiff, Cannon, and Jackson-Lee

    Lobbying Players:

    • www.innovationalliance.net (Tech Companies who want strong patents)
    • www.ipo.org (Industry group — Formerly supported strong IP rights — now a consensus builder — noting that “the battle-of-the-industries description of patent reform is simplistic and sensationalist.”)
    • www.phrma.org (Big Pharma: Strong patent rights)
    • www.patentsmatter.com
    • www.patentfairness.org (“Over-broad patent grants stifle future innovators, while unjustified lawsuits that aim to extort settlements”)
    • www.aipla.org (Group of lawyers who are, for the most part, unwilling to take a stand)
    • www.bsa.org (Microsoft, Apple, HP — all supporting dramatic patent reform that curbs litigation in favor of the more genteel cross-licensing).

    Who is writing about patent reform:

    News & PR:

    Call for Papers:

    • I would like to publish a couple of well written editorials on patent reform within the next two weeks. Feel free to submit yours to dcrouch@gmail.com.

    Patent Reform Act of 2007

    On April 18, 2007, bipartisan legislators in both the Senate and House of Representatives introduced sweeping patent reform measures in legislation termed the Patent Reform Act of 2007. The reform measures include the following provisions: 

    • First-to-file rights and elimination of interference proceedings;
    • Reform to make it easier to file a patent application without the inventor’s cooperation;
    • Limitation of damages to only the economic value of the improvement as compared to the prior-art;
    • Specific limitations on when damages may be trebled for willfulness;
    • Post-grant opposition proceedings with a reduction in the litigation estoppel effect;
    • Limitations on patent venue;
    • Authority to the PTO director to create further regulations.

    Although couched in terms of the importance of patents and patent quality. The thrust of many of the measures are clearly directed at “limiting litigation abuses.”  Although a detailed analysis has not been completed, the two versions appear virtually identical.

    Legislative Documents:

    Congressional Players:

    • The Senate version was introduced by Senators Leahy, Hatch, Schumar, and Cornyn
    • The House version was introduced by Representatives Berman, Smith, Conyers, Coble, Boucher, Godlatte, Zoe Lofgren, Issa, Schiff, Cannon, and Jackson-Lee

    Lobbying Players:

    • www.innovationalliance.net (Tech Companies who want strong patents)
    • www.ipo.org (Industry group — Formerly supported strong IP rights — now a consensus builder)
    • www.phrma.org (Big Pharma: Strong patent rights)
    • www.patentsmatter.com
    • www.patentfairness.org (“Over-broad patent grants stifle future innovators, while unjustified lawsuits that aim to extort settlements”)
    • www.aipla.org (Group of lawyers who are, for the most part, unwilling to take a stand)
    • www.bsa.org (Microsoft, Apple, HP — all supporting dramatic patent reform that curbs litigation in favor of the more genteel cross-licensing).

    Who is writing about patent reform:

    News:

    Patently-O plans to publish a couple of well written editorials on patent reform within the next two weeks. Feel free to submit yours to dcrouch@gmail.com.

    Patent Venue and Jurisdiction: Why E.D. Texas?

    28 USC 1400(b) is the primary patent venue statute. Under the statute, a patent infringement lawsuit may be filed in a jurisdiction (a) where the defendant resides; or (b) where the infringement occurred — so long as the defendant has a “regular and established place of business” in that jurisdiction.

    Any civil action for patent infringement may be brought in the judicial district where the defendant resides, or where the defendant has committed acts of infringement and has a regular and established place of business. 28 USC 1400

    1400(b) has been around for a long time and has (historically) been given narrow interpretation. Corporate residence was often limited to the location of the principal place of business or corporate headquarters and an established place of business did not include stores owned by others or sales-persons covering the locale. Numerous patent cases were dismissed or transferred because the defendant did not meet the requirements of the law. For instance, in the 1964 case of Sheldon v. Norbute, a Pennsylvania district court transferred the patentee’s case to New York even though the infringement occurred in Pennsylvania. According to the court, the defendant did not fit under the statute because it did not “maintain, control, or pay for an establishment in the district.”

    In 1990, Congress took to the pen and broadened the definition of a defendant’s “residence” to include any jurisdiction where the court has personal jurisdiction.

    For purposes of venue under this chapter, a defendant that is a corporation shall be deemed to reside in any judicial district in which it is subject to personal jurisdiction at the time the action is commenced. 28 USC 1391

    In VE Holdings (1990), the Federal Circuit interpreted the amended statute — determining that the statute’s “language is clear and its meaning is unambiguous.”  The appellate panel held that the new statute eviscerats the limitations of Section 1400(b) and allows for patent infringement suits in any jurisdiction where the defendant has sufficient contacts under the constitution.

    This leads us to last week — where Orion IP filed suit against 63 defendants in the sparsely populated Eastern District of Texas.  It appears that only a handful of these large corporate defendants have any connection to the jurisdiction beyond a mere ‘stream of commerce’ analysis.  Is it time to return some teeth to Section 1400?

    The Senate’s Patent Reform Bill of 2006 (S.3818) would have amended §1400 to, for the most part, eliminate the 1990 expansion.  Under that proposal, the revised venue statute would read as follows:

    (b) Any civil action arising under any Act of Congress relating to patents, other than an action for declaratory judgment … may be brought only — (1) in the judicial district where either party resides; or (2) in the judicial district where the defendant has committed acts of infringement and has a regular and established place of business.

    (c) Notwithstanding section 1391(c) of this title, for purposes of venue under subsection (b), a corporation shall be deemed to reside in the judicial district in which the corporation has its principal place of business or in the State in which the corporation is incorporated.

    The proposal still goes beyond the original scope of §1400 by allowing suits in jurisdictions based on the residence of either the plaintiff or defendant. 

    • Full Disclosure: Several of MBHB’s are defendants in the Orion case. These comments are my own and not those of MBHB or its clients.

    Supreme Court: Pharmaceutical Reverse Payments May be Considered by Supreme Court

    In an order today, the Supreme Court asked the US Solicitor General for the Gov’ts views on Joblove v. Barr Labs.  This case, also known as Tamoxifen Citrate Antitrust Litigation, questions the antitrust viability of reverse-payment settlements

    Pharmaceutical patent owners and generic makers have been accused of cooperating in a scheme to prop-up drug prices.  In a number of cases, generic manufacturers have received payments from patent owners as incentive to drop patent challenges. So far the courts have OK’d the agreements, but the Government is pushing its case for enforcement of the Antitrust laws.

    Over the past few years, the FTC & DOJ have been at-odds on whether this business practice represents a problem.

    In 2006, FTC v. Schering-Plough, a similar case was presented to the Supreme Court. There, the DOJ filed a brief indicating its disagreement with the FTC and arguing that the high court should not hear the case. In its brief, the DOJ indicated that the Tamoxifen litigation (this case) would be a better avenue for the Supreme Court’s focus.  After hearring the DOJ’s argument, the Supreme Court denied cert in Schering-Plough.

    Microsoft v. AT&T: Transnational patent Law

    Microsoft v. AT&T (Supreme Court 2007).

    Section 271(f) of the Patent Act expands the territorial scope of US patent protection by creating liability for exporting one or more “components” of a patented invention so that the whole invention may be practiced abroad. The statute is divided into parts one and two dealing with inducement and contributory activity respectively.

    The case at hand involves Microsoft’s infringement of AT&T’s speech coding technology patent. Microsoft has conceded that its software (once installed on a computer) infringes the patent in the US. However, Microsoft has fought against paying patent royalties for sale of the same software abroad.  Microsoft’s argument, spelled out in its brief, is two-fold: (1) Software cannot be a ‘component’ as required by the statute because software code is intangible; and (2) Software copies made abroad cannot be considered ‘supplied’ from the US as required by the statute because no physical particle that Microsoft exported actually became part of the finished product.  I have previously labeled these arguments as the tangibility requirement and the molecular conservation requirement. [Link]

    Now, AT&T and its supporters has filed their briefs that explain why 271(f) should encompass foreign copies of software shipped from the US. [Petitioner and Gov’t briefs are discussed here]

    AT&T’s Brief on the Merits:

    Tangibility: AT&T attacks the tangibility requirement head-on, arguing that there is no such requirement.

    [The software] is plainly a component of [the patented] device, just as a unique collection of intangible words is a component of any book bearing the title Moby-Dick, even though those words, too, must be combined with ink and paper before the book can be read.

    Of course AT&T is correct — the statute does not spell-out any tangibility requirement, and Microsoft’s statutory argument is, at best implicit. AT&T’s arguments are supported by business practice as well. Software and hardware are developed and sold separately, and each side can easily be though of as providing components of the whole.

    Molecular Conservation Requirement: AT&T takes a different view of the statutory requirement that the components be “supplied” from the US. In AT&T’s story, “supplied” means satisfying a need or furnishing.  Using a but-for analysis, AT&T makes clear that without Microsoft’s shipment of the code abroad, it would not have ended-up in the foreign computers.

    Here, the Windows object code is present in the foreign made computers only because Microsoft “provided” or “furnished”—in a word, supplied—it from the United States, via golden master disk or electronic transmission.

    As it stands, the AT&T brief is well written and convincing on its own — the major problem being that it leads with a petty argument for dismissal.

    Philips Corporation also filed a brief in support of AT&T.  Philips makes several arguments, two of which I discuss here:

    1. In today’s market, software and hardware companies do compete head-to-head.  A finding that software export is noninfringing would be at the expense of electronics companies because hardware exports would continue to be considered infringing.  Thus, awarding the win to Microsoft here may free the software industry, but will even further damage the hardware export industry.
    2. In many ways, this case is about the size of damages. Microsoft hopes that copies made abroad will not be seen as infringing because those copies were not literally shipped from the US.  Philips points out under the rules of consequential damage calculations, Microsoft would owe damages for sales of all copies even if 271(f) only covered the initial master disk shipment.

    WARF, California, and RCTech filed a joint brief in support of AT&T. These holders of strong bio-related patents see the potential that this case could narrow the scope of their protection. WARF points-out how Microsoft comes to the table with unclean hands:

    When it suits its interests, even Microsoft acknowledges that the number of units it supplies is not limited by the number of golden masters it sends abroad. In Microsoft Corp. v. Comm’r of Internal Revenue, Microsoft argued that it was entitled to tax deductions . . . for all foreign sales of software replicated from Microsoft’s golden master abroad, claiming that such copies were “export property” under the statute. The Ninth Circuit . . . agreed with Microsoft that all copies created from the golden master were export property, thereby providing Microsoft with another $31 million in claimed deductions for 1990 and 1991.

    BAYHDOLE25.inc is an educational NGO that supports, as you might guess, the Bayh Dole act (at its 25th anniversary).  In a brief supporting AT&T, BD25 argues for the protection of intangible assets — especially assets that are replicable and intended to be replicated.  These include software code, cell lines, patented seeds, DNA, etc. Replicable assets are important and should be protectable.

    Documents:

    • On the Merits
    • In Support of Microsoft
  • In Support of AT&T
  • In Support of Neither Party
  • Reply Brief:
  • On Petition for Certiorari
  • Important recent 271(f) cases:

    • NTP v. Research in Motion, (271(f) “component” would rarely if ever apply to method claims).
    • AT&T v. Microsoft, 414 F.3d 1366 (Fed. Cir. 2005) (271(f) “component” applies to method claims and software being sold abroad);
    • Union Carbide v. Shell Oil (Fed. Cir. 2005) (271(f) “component” applies to method claims).
    • Eolas v. Microsoft, 399 F.3d 1325 (Fed. Cir. 2005) (271(f) “component” applies to method claims and software);
    • Pellegrini v. Analog Devices, 375 F.3d 1113 (Fed. Cir. 2004) (271(f) “component” does not cover export of plans/instructions of patented item to be manufactured abroad);
    • Bayer v. Housey Pharms, 340 F.3d 1367 (Fed. Cir. 2003) (271(g) “component” does not apply to importation of ‘intangible information’).

    Earlier Discussion of this case

    Text of 35 USC 271(f)

    (1) Whoever without authority supplies or causes to be supplied in or from the United States all or a substantial portion of the components of a patented invention, where such components are uncombined in whole or in part, in such manner as to actively induce the combination of such components outside of the United States in a manner that would infringe the patent if such combination occurred within the United States, shall be liable as an infringer.

    (2) Whoever without authority supplies or causes to be supplied in or from the United States any component of a patented invention that is especially made or especially adapted for use in the invention and not a staple article or commodity of commerce suitable for substantial noninfringing use, where such component is uncombined in whole or in part, knowing that such component is so made or adapted and intending that such component will be combined outside of the United States in a manner that would infringe the patent if such combination occurred within the United States, shall be liable as an infringer.

    (more…)